향사양위탕이 시스플라틴 유발 랫트의 위장관 기능 장애에 미치는 영향 = Beneficial Effect of Hyangsayangwi-tang on the Cisplatin-Induced Gastrointestinal Dysfunctions in Rats

다국어 초록 (Multilingual Abstract)

Objectives This study aimed to observe the effect of Hyangsayangwi-tang on the cisplatin-induced gastrointestinal dysfunctions in rats. Methods Four groups(each of 8 rats per group) were used in this study. Saline and distilled water treated control rats are Intact vehicle control group. Delayed gatrointestinal mortility was induced by intraperitoneal treatment of cisplatin 2mg/kg, once a week for 5 weeks(Cisplatin control group). Hyangsayangwi-tang aqueous extracts(HY) were orally administered in a volume of 5ml/kg, once a day for 14 days from 4th ciplatin treatmernt(HY group). Ondansetron 1mg/kg was subcutaneously treated, in a volume of 1ml/kg, as same as HY(ondansetron group). We measured the body weights, intestinal charcoal transit ratio, fecal parameters, fundus MDA, GSH contents and SOD, CAT activities, TPH and MAO activities, pyloric gastrin and serotonin contents with their immunoraective cells, colonic serotonin-immunoreactive cells, the histopathology of pylorus, fundus mucosa and colon. Results and Conclusions (1) The body weight gains, the small intestinal charcoal transfer rates, the fecal parameters(numbers, weights and water contents) were increased in HY, ondansetron group. (2) The inhibit of fundus antioxidant defense systems by cisplatin were decreased in HY, ondansetron group. (3) The pyloric TPH activities were increased and the pyloric MAO activities were decreased in HY group. (4) The pyloric gastric contents and the gastrin-immunoreactive cells were increased in HY group. And the pyloric serotonin contents and the pyloric and colonic serotonin-immunoreactive cells were decreased in HY group. (5) The pyloru atrophic changes and the gastric surface erosive damage regions by cisplatin were favorably inhibited by treatment of HY. HY, a representative Soeumin prescription improve GI dysfunctions and constipation retarded by cisplatin through modulations of GI enterochromaffin cells, serotonin and gastrin-producing cells and antioxidative systems. Especially HY showed the highest favorable effects more than those of ondansetron.

참고문헌 (Reference)

1 김현경, "시스플라틴과 녹차 추출물의 병용에 의한 세포성장 저해 효과" 대한부인종양학회 17 (17): 347-353, 2006

2 안창범, "黃芩藥鍼液이 Cisplatin에 의해 유발된 急性腎不全에 미치는 영향" 대한침구의학회 19 (19): 156-167, 2002

3 최병철, "香砂養胃湯 전탕액이 노화쥐의 비장, 췌장, 위장 세포의 항산화능에 미치는 영향" 사상체질의학회 20 (20): 72-84, 2008

4 조시용, "車前子藥鍼이 急性腎不全 白鼠에 미치는 影響" 경락경혈학회 22 (22): 117-127, 2005

5 김진철, "苦參이 抗癌劑 cisplatin의 肝？腎臟 副作用 減少에 미치는 影響" 경락경혈학회 22 (22): 165-174, 2005

6 한경석, "少陰人 藥理의 形成過程 관한 硏究- 甲午本과 辛丑本을 중심으로 -" 사상체질의학회 18 (18): 15-24, 2006

7 남주영, "半枝蓮과 항암제 병용 투여에 의한 암세포 성장 저해에 관한 연구" 대한한방부인과학회 22 (22): 125-139, 2009

8 Bradner WT, "Toxicology screening in small animals" 8 (8): 93-102, 1981

9 Wintola OA, "The effect of Aloeferox Mill. in the treatment of loperamide-induced constipationin Wistarrats" 10 : 95-, 2010

10 Kim KY, "The Theoretical Analysis on Soeumin-Hyangsayangwi-tang" 4 (4): 213-219, 1992

11 Andrews PL, "Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases" 125 (125): 100-115, 2006

12 National federation of department of sasang constitutional medicine, "Sasang constitutional medicine" Jipmoondang 260-480, 2004

13 Wang Y, "Role of vitamin d on the inhibition of gastrin production after Cisplatin treatment" 7 (7): 115-119, 2000

14 Chirino YI, "Role of oxidative and nitrosative stress in cisplatin induced nephrotoxicity" 61 (61): 223-242, 2009

15 Gershon MD, "Release of endogenous 5-hydroxytryptamine from resting and stimulated enteric neurons" 6 (6): 2277-2286, 1981

16 Lee HS, "Regional distribution and relative frequency of gastrointestinal endocrine cells in the ddN mice: an immunohistochemical study" 39 (39): 521-528, 2010

17 Rho YS, "Preventive Effect of Crude Drug Preparation (E-kong-san) on Cisplatin induced Nephrotoxicity" 29 (29): 258-264, 1998

18 Kishibayashi N, "Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, inrats:inhibition of the distal colonic function" 63 (63): 495-502, 1993

19 Lee JC, "New Sasang Constitutional Medicine 2" Wood and Earth 79-249, 2003

20 Comporti M., "Lipid peroxidation and cellular damage in toxic liver injury" 53 (53): 599-623, 1985

21 Chang B, "L-Carnitine inhibits cisplatin induced injury of the kidney and small intestine" 405 (405): 55-64, 2002

22 Badary OA, "In vitro and in vivo effects of ferulic acid on gastrointestinal motility: inhibition of cisplatin-induced delay in gastric emptying in rats" 12 (12): 5363-5367, 2006

23 Institute for Laboratory Animal Research, "Guide for the Care and Use of Laboratory Animals" The national academics press 162-166, 1985

24 Odabasoglu F, "Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats" 103 (103): 59-65, 2006

25 Lee GN, "File of Clinical Pathology" Medical Culture 526-527, 1993

26 Sagar L, "Evaluation of antimotility effect of Lantanacamara L. var. acuelata constituents on neostigmine induced gastrointestinal transit in mice" 5 : 18-, 2005

27 Hafermann MJ, "Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study" 3 : 53-58, 2011

28 Lee JM, "Donguisusebowon" Eulyoo Publishing Co., Ltd 27-278, 2002

29 Malik NM, "Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats" 555 (555): 164-173, 2007

30 Süleyman H, "Comparative study on the gastroprotective potential of some antidepressants in indomethacininduced ulcer in rats" 180 (180): 318-324, 2009

31 Lebwohl D, "Clinical development of platinum complexes in cancer therapy: an historical perspective and an update" 34 (34): 1522-1534, 1998

32 Yang ZH, "Cellular mechanisms underlying the laxative effect of flavonol naringenin on rat constipation model" 3 (3): e3348-, 2008

33 조수인, "Beneficial Effect of Nodus Nelumbinis Rhizomatis Extract on Cisplatin-Induced Kidney Toxicity n Rats" 대한본초학회 18 (18): 16-134, 2003

34 Martin C, "Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation" 149 (149): 631-636, 1998

35 Martin C, "Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation" 149 (149): 631-636, 1998

36 SM Ahn, "Anti-Emetic Efficacy of Ondansetron Plus Desamethasone in Cisplatin- Based Combination Chemotherapy" 37 (37): 976-994, 1994

37 Cheeseman KH, "An introduction to free radical biochemistry" 49 (49): 481-493, 1993

38 Kim KY, "An Experimental Study on Some Effects of Soeumin-Hyangsayangwi-tang" 1 (1): 153-170, 1989

39 Kim YB, "A Randomized Comparison of Tropisetron versus Ondansetron in the Control of Nausea and Vomiting in Gynecologic Cancer Patients Undergone Cisplatin- Based Chemotherapy" 41 (41): 2544-2550, 1998

40 Huh So, "A 6.1 kb 5' upstream region of the mouse tryptophan hydroxylase gene directs expression of E, coli lacZ to major serotonergic brain region and pineal pland in transgenic mice" 24 (24): 145-152, 1994

41 Tyers MB, "5-HT3 receptors and the therapeuticpotential of 5-HT3 receptor antagonists" 46 (46): 431-435, 1991